➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
McKesson
Medtronic
Baxter
Harvard Business School

Last Updated: June 16, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Roxadustat


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Roxadustat?

Roxadustat is an investigational drug.

There have been 26 clinical trials for Roxadustat. The most recent clinical trial was a Phase 1 trial, which was initiated on October 20th 2019.

The most common disease conditions in clinical trials are Anemia, Renal Insufficiency, Chronic, and Kidney Diseases. The leading clinical trial sponsors are FibroGen, AstraZeneca, and Astellas Pharma Europe B.V.

There are forty-nine US patents protecting this investigational drug and three hundred and seventy-eight international patents.

Recent Clinical Trials for Roxadustat
TitleSponsorPhase
Study of Roxadustat in the Treatment of Acute Myocardial InfarctionRuijin HospitalPhase 2
A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)ParexelPhase 4
A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)AstraZenecaPhase 4

See all Roxadustat clinical trials

Clinical Trial Summary for Roxadustat

Top disease conditions for Roxadustat
Top clinical trial sponsors for Roxadustat

See all Roxadustat clinical trials

US Patents for Roxadustat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Roxadustat   Get Started Free Nitrogen-containing heteroaryl compounds and methods of use thereof FibroGen, Inc. (San Francisco, CA)   Get Started Free
Roxadustat   Get Started Free Crystalline forms of a prolyl hydroxylase inhibitor FibroGen, Inc. (San Francisco, CA)   Get Started Free
Roxadustat   Get Started Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Baxter
Colorcon
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.